Exhibit 99.1

For Immediate Release
Investor Contact:
Matt Kreps
Halliburton Investor Relations
(972) 458-8000 (mkreps@halliburtonir.com)


             HEALTHAXIS REPURCHASES ALL ITS SECURITIES HELD BY UICI
      COMPANY BUYS COMMON STOCK, PREFERRED STOCK, WARRANTS FOR $3.9 MILLION

Irving, TX (September 30, 2003) - Healthaxis Inc. (NASDAQ:HAXS) announced today
that it has purchased all Healthaxis securities (common shares, preferred shares
and warrants) held by UICI for $3.9 million. The UICI holdings included
2,585,769 shares of Healthaxis' common stock, or 48.3 percent of Healthaxis'
outstanding common stock; 1,424 shares of Series A Convertible Preferred Stock,
or 6.1 percent of the outstanding preferred stock; and warrants to purchase
22,239 shares of common stock. The repurchased securities will be retired.

The total purchase price of $3.9 million includes $500,000 cash at closing, and
$3,400,000 in a 3-year promissory note bearing 6 percent interest. The
promissory note will be repaid through deductions from the monthly invoices for
BPO services provided by Healthaxis to the MEGA Life & Health Insurance Company,
a subsidiary of UICI. The exact monthly payment will be equal to approximately
half of the invoice amount for these services, with a minimum payment due each
month. The amount of any balloon principal payment due at maturity of the note
will depend on business volumes received from MEGA over the next three years.

To gain the required approval of this transaction from the Series A Preferred
Shareholders, Healthaxis agreed to reduce the conversion price of the remaining
preferred shares from $26.25 to $15.50. With the completion of the UICI
transaction, the total stated value of preferred stock outstanding was reduced
from $23.5 million to $22.1 million.

The repurchase of the UICI common shares reduces the total number of outstanding
Healthaxis common shares from 5,353,715 shares to 2,767,946 shares. The total
number of common equivalent shares held by both the common and preferred
shareholders prior to this transaction was 6,248,953. Following the repurchase
of the Healthaxis securities held by UICI, and after giving effect to the new
conversion price applicable to the preferred stock, the total number of common
equivalent shares held by both the common and preferred shareholders has been
reduced to 4,192,204 shares, a reduction of approximately 33 percent.

Commenting on the repurchase agreement with UICI, Healthaxis Chairman, President
and CEO, James McLane said, "We believe this repurchase of UICI's entire
remaining ownership position in the company on these terms is in the best
interest of all Healthaxis' shareholders. This transaction is another step
forward for Healthaxis."




About Healthaxis Inc.

Healthaxis (NASDAQ: HAXS) is a technology and business process services firm
committed to providing innovative and configurable Web-based connectivity and
applications solutions for health benefit distribution and administration. These
solutions, which are comprised of software products and related services, are
designed to assist health insurance payers, government agencies, third party
administrators (TPAs) and health and welfare plans provide enhanced services to
members, employees and providers through the application of Healthaxis' flexible
technology to legacy systems, either on a fully integrated or on an Application
Service Provider (ASP) basis. These technology solutions are complemented by the
company's Business Process Outsourcing (BPO) services that are offered to its
technology clients and on a stand-alone basis. Healthaxis solutions enable
clients to reduce their administrative costs, enhance their customer service and
improve their profitability. For information on Healthaxis products and
services, call (800) 519-0679 or visit www.healthaxis.com. For investor
information, call (972) 458-8000.

                                      # # #

Forward-looking statements

Statements that are not purely historical facts, including without limitation
statements about anticipated or expected future revenue and performance,
constitute forward-looking statements within the meaning of Section 27A of the
Securities and Exchange Act of 1934, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These forward-looking statements
are subject to known and unknown risks, uncertainties and other factors, which
may cause actual results to be materially different from those contemplated by
the forward-looking statements. Such factors include without limitation the
risks and uncertainties identified in our documents filed with, or furnished to,
the Securities and Exchange Commission, including those identified under the
caption "Business-Risk Factors" in our Form 10-K for the year ended December 31,
2002. We undertake no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise. Readers are cautioned not to place undue reliance on
forward-looking statements.

                                        #